Phenotypic and functional comparison of mobilized peripheral blood versus umbilical cord blood megakaryocyte populations.

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med (2004) 7.10

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood (2010) 4.02

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet (1992) 3.76

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med (2000) 3.19

CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo. Development (2003) 3.09

Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood (1988) 2.24

Filgrastim (r-metHuG-CSF): the first 10 years. Blood (1996) 1.99

CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age. Blood (2013) 1.74

Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood (2002) 1.41

Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood (2000) 1.32

Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant (1992) 1.29

Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells (2006) 1.16

Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates. Blood (2001) 1.00

Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production. Tissue Eng Part A (2013) 0.98

Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol (2003) 0.96

Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev (2005) 0.95

Umbilical cord blood transplantation: current state of the art. Curr Opin Oncol (2002) 0.94

Limited potential of circulating haemopoietic stem cells. Nature (1975) 0.93

Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant (1992) 0.90

Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation. Br J Haematol (2001) 0.87

Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia. Exp Hematol (1981) 0.86

Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol (2000) 0.85

Umbilical cord blood produces small megakaryocytes after transplantation. Biol Blood Marrow Transplant (2007) 0.85

Functional characterization of TPO-expanded CD34+ cord blood cells identifies CD34- CD61- cells as platelet-producing cells early after transplantation in NOD/SCID mice and rCD34+ cells as CAFC colony-forming cells. Stem Cells (2012) 0.85

Identification of megakaryocyte precursors in peripheral blood stem cell collections from normal donors. J Clin Apher (1998) 0.79